Clinical Trial Update: A Phase II Trial of ZIO-101 in Advanced Multiple Myeloma: Protocol SGL2001b [Phase 2]

View source ↗

Summary

This document provides an update on the Phase II trial protocol (SGL2001b) for ZIO-101 in advanced multiple myeloma and does not report trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• ZIO-101

Snippet

Sponsor: Alaunos Therapeutics | Conditions: Multiple Myeloma | Phase 2 | Status: UNKNOWN